Livzon Pharma Sets 21 August 2026 Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express08-06

Livzon Pharmaceutical Group Inc. (Livzon Pharma) will convene its board of directors on 21 August 2026. The agenda includes consideration and approval of the unaudited interim financial results for the six months ended 30 June 2026, along with other corporate matters.

The meeting notification, dated 6 August 2026, was issued by Company Secretary Liu Ning from Zhuhai, China.

Board composition as of the notice date: • Executive Directors: President Liu Daping and Vice Chairman Tang Yanggang • Non-Executive Directors: Chairman Zhu Baoguo, Lin Nanqi and Qiu Qingfeng • Employee Representative Director: Ran Yongmei • Independent Non-Executive Directors: Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li

No further financial figures or operational details were provided in the announcement. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the content’s accuracy or completeness.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1117132533?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117132533","market":"us","top_or_hot":-1,"title":"Livzon Pharma Sets 21 August 2026 Board Meeting to Approve 1H 2026 Interim Results","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) will convene its board of directors on 21 August 2026. The agenda includes consideration and approval of the unaudited interim financial results for the six months ended 30 June 2026, along with other corporate matters.</p>\n<p>The meeting notification, dated 6 August 2026, was issued by Company Secretary Liu Ning from Zhuhai, China.</p>\n<p>Board composition as of the notice date:\n• Executive Directors: President Liu Daping and Vice Chairman Tang Yanggang  \n• Non-Executive Directors: Chairman Zhu Baoguo, Lin Nanqi and Qiu Qingfeng  \n• Employee Representative Director: Ran Yongmei  \n• Independent Non-Executive Directors: Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li</p>\n<p>No further financial figures or operational details were provided in the announcement. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the content’s accuracy or completeness.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Sets 21 August 2026 Board Meeting to Approve 1H 2026 Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Sets 21 August 2026 Board Meeting to Approve 1H 2026 Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-06 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) will convene its board of directors on 21 August 2026. The agenda includes consideration and approval of the unaudited interim financial results for the six months ended 30 June 2026, along with other corporate matters.</p>\n<p>The meeting notification, dated 6 August 2026, was issued by Company Secretary Liu Ning from Zhuhai, China.</p>\n<p>Board composition as of the notice date:\n• Executive Directors: President Liu Daping and Vice Chairman Tang Yanggang  \n• Non-Executive Directors: Chairman Zhu Baoguo, Lin Nanqi and Qiu Qingfeng  \n• Employee Representative Director: Ran Yongmei  \n• Independent Non-Executive Directors: Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li</p>\n<p>No further financial figures or operational details were provided in the announcement. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the content’s accuracy or completeness.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1117132533","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117132533","pubTimestamp":1786006992,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) will convene its board of directors on 21 August 2026. The agenda includes consideration and approval of the unaudited interim financial results for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药定于2026年8月21日召开董事会会议，批准2026年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) will convene its board of directors on 21 August 2026. The agenda includes consideration and approval of the unaudited interim financial results for the six months ended 30 June 2026, along with other corporate matters.\nThe meeting notification, dated 6 August 2026, was issued by Company Secretary Liu Ning from Zhuhai, China.\nBoard composition as of the notice date:\n• Executive Directors: President Liu Daping and Vice Chairman Tang Yanggang  \n• Non-Executive Directors: Chairman Zhu Baoguo, Lin Nanqi and Qiu Qingfeng  \n• Employee Representative Director: Ran Yongmei  \n• Independent Non-Executive Directors: Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li\nNo further financial figures or operational details were provided in the announcement. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited have disclaimed responsibility for the content’s accuracy or completeness.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1117132533","isCrawlerRequest":true}